Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease
Crossref DOI link: https://doi.org/10.1007/s00467-017-3584-9
Published Online: 2017-02-13
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gilbert, Rodney D.
Evans, Hazel
Olalekan, Kazeem
Nagra, Arvind
Haq, Mushfequr R.
Griffiths, Mark
Funding for this research was provided by:
University of Southampton
License valid from 2017-02-13